2024-513845-36-00已完成1 期
Evaluation of vamorolone CYP3A4 induction on midazolam (a sensitive CYP3A4 substrate) pharmacokinetics
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 18
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Catherine Dutreix
Scientific
Santhera Pharmaceuticals (Schweiz) AG
研究点 (1)
Loading locations...
相似试验
招募中
不适用
A non-interventional study to assess CYP3A induction by high-dose systemic glucocorticoids and by mitotane using 4ß-hydroxycholesterol as a biomarkerAny disease, which requires a therapy with high-dose prednisolone/prednisone, dexamethasone, a biological immunosuppressive therapy (patients with autoimmune/chronic inflammatory diseases) OR with an indication to start a therapy with mitotane (adrenocortical carcinoma patients)DRKS00018093Institut I für Pharmakologie,Universitätsklinikum Köln (AöR)64
进行中（未招募）
不适用
PHARMACOKINETICS OF VORICONAZOLE DURING CONTINUOUS VENOVENOUS HEMODIAFILTRATION - Voriconazole during CVVHDFEUCTR2004-003479-35-ATInternal Medicine IV, Mecdical University of Vienna7
已完成
不适用
Study of the effectiveness of voriconazole in the treatment of Aspergillus fumigatus associated asthmaAsthmaRespiratoryISRCTN42366088niversity Hospitals of Leicester NHS Trust (UK)70
进行中（未招募）
1 期
Study of the effectiveness of Voriconazole in the treatment of Aspergillus fumigatus associated asthma - Effectiveness of Voriconazole in Aspergillus associated asthmaAsthma with sensitization to aspergillus and isolation in sputum.EUCTR2009-011452-21-GBniversity Hospitals of Leicester NHS trust
进行中（未招募）
1 期
An open-label Phase I Trial of the CYP3A Inhibitor Cobicistat and the cytostatics Gemcitabine and nab-Paclitaxel in Patients with Advanced Stage or metastatic Pancreatic Ductal Adenocarcinoma to evaluate the combination's Pharmacokinetics, Safety and Efficacy (IntenSify).C25.3Pancreatic ductDRKS00029409Deutsches Krebsforschungszentrum6